Literature DB >> 21088442

Variants of the adenosine A(2A) receptor gene are protective against proliferative diabetic retinopathy in patients with type 1 diabetes.

Bashira A Charles1, Yvette P Conley, Guanjie Chen, Rachel G Miller, Janice S Dorman, Michael B Gorin, Robert E Ferrell, Susan M Sereika, Charles N Rotimi, Trevor J Orchard.   

Abstract

AIMS: The adenosine A(2A) receptor (ADORA(2A)) may ameliorate deleterious physiologic effects associated with tissue injury in individuals with diabetes. We explored associations between variants of the ADORA(2A) gene and proliferative diabetic retinopathy (PDR) in a cohort of patients with type 1 diabetes (T1D).
METHODS: The participants were from the Pittsburgh Epidemiology of Diabetes Complications prospective study of childhood-onset T1D. Stereoscopic photographs of the retinal fundus taken at baseline, then biennially, for 10 years were used to define PDR according to the modified Airlie House system. Two tagging single nucleotide polymorphisms (tSNPs; rs2236624-C/T and rs4822489-G/T) in the ADORA(2A) gene were selected using the HapMap (haplotype map) reference database.
RESULTS: A significant association was observed between SNP rs2236624 and PDR in the recessive genetic model. Participants homozygous for the T allele displayed a decreased risk of developing prevalent PDR (odds ratio, OR = 0.36; p = 0.04) and incident PDR (hazard ratio = 0.156; p = 0.009), and for all cases of PDR combined (OR = 0.23; p = 0.001). The protective effect of T allele homozygosity remained after adjusting for covariates. Similarly, for SNP rs4822489, an association between PDR and T allele homozygosity was observed following covariate adjustment (OR = 0.55; 95% CI: 0.31-0.92; p = 0.04).
CONCLUSION: Genetic variants of ADORA(2A) offer statistically significant protection against PDR development in patients with T1D.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21088442      PMCID: PMC2997447          DOI: 10.1159/000317057

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  49 in total

1.  The International HapMap Project.

Authors: 
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

Review 2.  Diabetic retinopathy.

Authors:  Robert N Frank
Journal:  N Engl J Med       Date:  2004-01-01       Impact factor: 91.245

3.  Vascular development in chick embryos: a possible role for adenosine.

Authors:  T H Adair; J P Montani; D M Strick; A C Guyton
Journal:  Am J Physiol       Date:  1989-01

4.  Familial clustering of diabetic retinopathy in South Indian Type 2 diabetic patients.

Authors:  M Rema; G Saravanan; R Deepa; V Mohan
Journal:  Diabet Med       Date:  2002-11       Impact factor: 4.359

5.  Characterization of genomic organization of the adenosine A2A receptor gene by molecular and bioinformatics analyses.

Authors:  Liqun Yu; Martin C Frith; Yutaka Suzuki; Robert A Peterfreund; Tom Gearan; Sumio Sugano; Michael A Schwarzschild; Zhiping Weng; J Stephen Fink; Jiang-Fan Chen
Journal:  Brain Res       Date:  2004-03-12       Impact factor: 3.252

6.  The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1984-04

7.  Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients.

Authors:  Charles Rotimi; Harold Daniel; Jie Zhou; Augustine Obisesan; Guanjie Chen; Yuanxiu Chen; Albert Amoah; Victoria Opoku; Joseph Acheampong; Kofi Agyenim-Boateng; Benjamin Ackon Eghan; Johnnie Oli; Godfrey Okafor; Ester Ofoegbu; Babatunde Osotimehin; Fayeofori Abbiyesuku; Thomas Johnson; Olufemi Fasanmade; Ayo Doumatey; Temilolu Aje; Francis Collins; Georgia Dunston
Journal:  Ethn Dis       Date:  2003       Impact factor: 1.847

8.  Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A(2A) receptor agonists and endotoxin.

Authors:  Samuel Joseph Leibovich; Jiang-Fan Chen; Grace Pinhal-Enfield; Paula C Belem; Genie Elson; Anthony Rosania; Madhuri Ramanathan; Carmen Montesinos; Marlene Jacobson; Michael A Schwarzschild; J Stephen Fink; Bruce Cronstein
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

9.  Are seven standard photographic fields necessary for classification of diabetic retinopathy?

Authors:  S E Moss; S M Meuer; R Klein; L D Hubbard; R J Brothers; B E Klein
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-05       Impact factor: 4.799

10.  Enhancement of P2X(7)-induced pore formation and apoptosis: an early effect of diabetes on the retinal microvasculature.

Authors:  Tetsuya Sugiyama; Masato Kobayashi; Hajime Kawamura; Qing Li; Donald G Puro; Masato Kobayshi
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-03       Impact factor: 4.799

View more
  6 in total

Review 1.  Adenosine receptors and caffeine in retinopathy of prematurity.

Authors:  Jiang-Fan Chen; Shuya Zhang; Rong Zhou; Zhenlang Lin; Xiaohong Cai; Jing Lin; Yuqing Huo; Xiaoling Liu
Journal:  Mol Aspects Med       Date:  2017-01-11

Review 2.  Adenosine signalling in diabetes mellitus--pathophysiology and therapeutic considerations.

Authors:  Luca Antonioli; Corrado Blandizzi; Balázs Csóka; Pál Pacher; György Haskó
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

3.  Adenosine A1 Receptors Selectively Modulate Oxygen-Induced Retinopathy at the Hyperoxic and Hypoxic Phases by Distinct Cellular Mechanisms.

Authors:  Shuya Zhang; Haiyan Li; Bo Li; Dingjuan Zhong; Xuejiao Gu; Lingyun Tang; Yanyan Wang; Cun Wang; Rong Zhou; Yan Li; Yan He; Mozi Chen; Yuqing Huo; Xiao-Ling Liu; Jiang-Fan Chen
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

4.  The association of ADORA2A and ADORA2B polymorphisms with the risk and severity of chronic heart failure: a case-control study of a northern Chinese population.

Authors:  Ya-Jing Zhai; Ping Liu; Hai-Rong He; Xiao-Wei Zheng; Yan Wang; Qian-Ting Yang; Ya-Lin Dong; Jun Lu
Journal:  Int J Mol Sci       Date:  2015-01-26       Impact factor: 5.923

5.  Endothelial adenosine A2a receptor-mediated glycolysis is essential for pathological retinal angiogenesis.

Authors:  Zhiping Liu; Siyuan Yan; Jiaojiao Wang; Yiming Xu; Yong Wang; Shuya Zhang; Xizhen Xu; Qiuhua Yang; Xianqiu Zeng; Yaqi Zhou; Xuejiao Gu; Sarah Lu; Zhongjie Fu; David J Fulton; Neal L Weintraub; Ruth B Caldwell; Wenbo Zhang; Chaodong Wu; Xiao-Ling Liu; Jiang-Fan Chen; Aftab Ahmad; Ismail Kaddour-Djebbar; Mohamed Al-Shabrawey; Qinkai Li; Xuejun Jiang; Ye Sun; Akrit Sodhi; Lois Smith; Mei Hong; Yuqing Huo
Journal:  Nat Commun       Date:  2017-09-19       Impact factor: 14.919

6.  Adenosine A2A receptor antagonists act at the hyperoxic phase to confer protection against retinopathy.

Authors:  Rong Zhou; Shuya Zhang; Xuejiao Gu; Yuanyuan Ge; Dingjuan Zhong; Yuling Zhou; Lingyun Tang; Xiao-Ling Liu; Jiang-Fan Chen
Journal:  Mol Med       Date:  2018-07-31       Impact factor: 6.354

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.